Depth and lateral spread of microscopic residual rectal cancer after neoadjuvant chemoradiation: Implications for treatment decisions

F. M. Smith, H. Wiland, A. Mace, Rish Pai, M. F. Kalady

Research output: Contribution to journalArticle

16 Citations (Scopus)

Abstract

Aim: The aim of this study was to determine the distribution of residual tumour within the bowel wall in relation to residual mucosal abnormalities (RMAs) and surrounding normal mucosa in patients with rectal cancer who underwent neoadjuvant chemoradiation followed by curative surgery. Method: Archived pathological slides from a cohort of 60 patients with residual tumour were retrieved. The incidence, distance and depth of tumour spread (ypT) under RMAs and adjacent normal mucosa were reviewed and recorded. Results: Histological sections containing both RMA and adjacent normal mucosa were available for 45 of 60 patients with ypT1 (n = 6), ypT2 (n = 18) and ypT3 (n = 21) disease. The maximal depth of invasion, as measured by ypT stage, was found underneath the RMA in 44 of 45 (98%) patients. Microscopic tumour spread lateral to the RMA and under adjacent normal mucosa was found in 32 of 45 (71%) patients. The median and maximum distances of lateral spread for ypT1 tumours were 0 and 4 mm; for ypT2 were 2.5 and 9 mm; and for ypT3 were 4 and 9 mm respectively. Conclusion: Lateral tumour spread under normal mucosa adjacent to RMAs is a common finding and extended up to 9 mm in this study. The epicentre for maximum depth of invasion was directly underneath the RMAs in nearly all cases. These data have clinical and technical implications if local excision is to be considered.

Original languageEnglish (US)
Pages (from-to)610-615
Number of pages6
JournalColorectal Disease
Volume16
Issue number8
DOIs
StatePublished - Jan 1 2014
Externally publishedYes

Fingerprint

Residual Neoplasm
Rectal Neoplasms
Mucous Membrane
Neoplasms
Therapeutics
Incidence

Keywords

  • Lateral spread
  • Neoadjuvant
  • Radiotherapy
  • Rectal cancer
  • Restaging
  • Tumour scatter

ASJC Scopus subject areas

  • Gastroenterology
  • Medicine(all)

Cite this

Depth and lateral spread of microscopic residual rectal cancer after neoadjuvant chemoradiation : Implications for treatment decisions. / Smith, F. M.; Wiland, H.; Mace, A.; Pai, Rish; Kalady, M. F.

In: Colorectal Disease, Vol. 16, No. 8, 01.01.2014, p. 610-615.

Research output: Contribution to journalArticle

@article{0a3a49a57de8499b855c29d42aadd601,
title = "Depth and lateral spread of microscopic residual rectal cancer after neoadjuvant chemoradiation: Implications for treatment decisions",
abstract = "Aim: The aim of this study was to determine the distribution of residual tumour within the bowel wall in relation to residual mucosal abnormalities (RMAs) and surrounding normal mucosa in patients with rectal cancer who underwent neoadjuvant chemoradiation followed by curative surgery. Method: Archived pathological slides from a cohort of 60 patients with residual tumour were retrieved. The incidence, distance and depth of tumour spread (ypT) under RMAs and adjacent normal mucosa were reviewed and recorded. Results: Histological sections containing both RMA and adjacent normal mucosa were available for 45 of 60 patients with ypT1 (n = 6), ypT2 (n = 18) and ypT3 (n = 21) disease. The maximal depth of invasion, as measured by ypT stage, was found underneath the RMA in 44 of 45 (98{\%}) patients. Microscopic tumour spread lateral to the RMA and under adjacent normal mucosa was found in 32 of 45 (71{\%}) patients. The median and maximum distances of lateral spread for ypT1 tumours were 0 and 4 mm; for ypT2 were 2.5 and 9 mm; and for ypT3 were 4 and 9 mm respectively. Conclusion: Lateral tumour spread under normal mucosa adjacent to RMAs is a common finding and extended up to 9 mm in this study. The epicentre for maximum depth of invasion was directly underneath the RMAs in nearly all cases. These data have clinical and technical implications if local excision is to be considered.",
keywords = "Lateral spread, Neoadjuvant, Radiotherapy, Rectal cancer, Restaging, Tumour scatter",
author = "Smith, {F. M.} and H. Wiland and A. Mace and Rish Pai and Kalady, {M. F.}",
year = "2014",
month = "1",
day = "1",
doi = "10.1111/codi.12608",
language = "English (US)",
volume = "16",
pages = "610--615",
journal = "Colorectal Disease",
issn = "1462-8910",
publisher = "Wiley-Blackwell",
number = "8",

}

TY - JOUR

T1 - Depth and lateral spread of microscopic residual rectal cancer after neoadjuvant chemoradiation

T2 - Implications for treatment decisions

AU - Smith, F. M.

AU - Wiland, H.

AU - Mace, A.

AU - Pai, Rish

AU - Kalady, M. F.

PY - 2014/1/1

Y1 - 2014/1/1

N2 - Aim: The aim of this study was to determine the distribution of residual tumour within the bowel wall in relation to residual mucosal abnormalities (RMAs) and surrounding normal mucosa in patients with rectal cancer who underwent neoadjuvant chemoradiation followed by curative surgery. Method: Archived pathological slides from a cohort of 60 patients with residual tumour were retrieved. The incidence, distance and depth of tumour spread (ypT) under RMAs and adjacent normal mucosa were reviewed and recorded. Results: Histological sections containing both RMA and adjacent normal mucosa were available for 45 of 60 patients with ypT1 (n = 6), ypT2 (n = 18) and ypT3 (n = 21) disease. The maximal depth of invasion, as measured by ypT stage, was found underneath the RMA in 44 of 45 (98%) patients. Microscopic tumour spread lateral to the RMA and under adjacent normal mucosa was found in 32 of 45 (71%) patients. The median and maximum distances of lateral spread for ypT1 tumours were 0 and 4 mm; for ypT2 were 2.5 and 9 mm; and for ypT3 were 4 and 9 mm respectively. Conclusion: Lateral tumour spread under normal mucosa adjacent to RMAs is a common finding and extended up to 9 mm in this study. The epicentre for maximum depth of invasion was directly underneath the RMAs in nearly all cases. These data have clinical and technical implications if local excision is to be considered.

AB - Aim: The aim of this study was to determine the distribution of residual tumour within the bowel wall in relation to residual mucosal abnormalities (RMAs) and surrounding normal mucosa in patients with rectal cancer who underwent neoadjuvant chemoradiation followed by curative surgery. Method: Archived pathological slides from a cohort of 60 patients with residual tumour were retrieved. The incidence, distance and depth of tumour spread (ypT) under RMAs and adjacent normal mucosa were reviewed and recorded. Results: Histological sections containing both RMA and adjacent normal mucosa were available for 45 of 60 patients with ypT1 (n = 6), ypT2 (n = 18) and ypT3 (n = 21) disease. The maximal depth of invasion, as measured by ypT stage, was found underneath the RMA in 44 of 45 (98%) patients. Microscopic tumour spread lateral to the RMA and under adjacent normal mucosa was found in 32 of 45 (71%) patients. The median and maximum distances of lateral spread for ypT1 tumours were 0 and 4 mm; for ypT2 were 2.5 and 9 mm; and for ypT3 were 4 and 9 mm respectively. Conclusion: Lateral tumour spread under normal mucosa adjacent to RMAs is a common finding and extended up to 9 mm in this study. The epicentre for maximum depth of invasion was directly underneath the RMAs in nearly all cases. These data have clinical and technical implications if local excision is to be considered.

KW - Lateral spread

KW - Neoadjuvant

KW - Radiotherapy

KW - Rectal cancer

KW - Restaging

KW - Tumour scatter

UR - http://www.scopus.com/inward/record.url?scp=84904387804&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84904387804&partnerID=8YFLogxK

U2 - 10.1111/codi.12608

DO - 10.1111/codi.12608

M3 - Article

C2 - 24593015

AN - SCOPUS:84904387804

VL - 16

SP - 610

EP - 615

JO - Colorectal Disease

JF - Colorectal Disease

SN - 1462-8910

IS - 8

ER -